The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAshmore Regulatory News (ASHM)

Share Price Information for Ashmore (ASHM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 199.20
Bid: 198.10
Ask: 198.40
Change: 2.90 (1.48%)
Spread: 0.30 (0.151%)
Open: 196.30
High: 199.50
Low: 196.30
Prev. Close: 196.30
ASHM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Statement

14 Jul 2023 07:00

RNS Number : 9887F
Ashmore Group PLC
14 July 2023
 

Ashmore Group plc14 July 2023

FOURTH QUARTER ASSETS UNDER MANAGEMENT STATEMENT

Ashmore Group plc ("Ashmore", "the Group"), the specialist Emerging Markets asset manager, announces the following update to its assets under management ("AuM") in respect of the quarter ended 30 June 2023.

Assets under management

Theme

Actual31 March 2023

(US$ billion)

Estimated30 June 2023

(US$ billion)

Movement

 (%)

- External debt

12.6

11.0

-13%

- Local currency

18.9

18.8

-1%

- Corporate debt

6.6

6.5

-2%

- Blended debt

12.3

11.9

-3%

Fixed income

50.4

48.2

-4%

Equities

5.9

6.2

+5%

Alternatives

1.4

1.5

+7%

Total

57.7

55.9

-3%

 

Assets under management decreased by US$1.8 billion over the period, comprising positive investment performance of US$1.1 billion and net outflows of US$2.9 billion.

The net outflows were primarily the result of top-down asset allocation decisions by institutional clients in the external debt theme and, to a lesser extent, in the blended debt and local currency themes. There was a small net outflow in corporate debt, and net flows were flat in the equities and alternatives themes.

Emerging Markets performed well over the quarter with returns of between +1% and +2.5% in the main benchmark indices. Local currency markets performed particularly well, supported by continued weakness in the US dollar and rapidly falling inflation in larger emerging economies. Over the three months, Ashmore delivered outperformance in local currency, equities and investment grade strategies, and underperformed in other external debt, corporate debt and blended debt strategies. Given the recovery in Emerging Markets asset prices and the consequent strength of Ashmore's investment performance over the past three quarters, as at 30 June, approximately two-thirds of the Group's AuM is outperforming over one and three years.

Mark Coombs, Chief Executive Officer, Ashmore Group plc, commented:

"There remains some global macro uncertainty and certain investors have therefore reduced risk during the quarter. However, Emerging Markets continue to perform well, with support from improving fundamentals such as accelerating GDP growth, falling inflation and the potential for rate cuts, as well as the benefit of a weaker US dollar. Against this developing backdrop, and as expected at this point in the cycle, Ashmore's active investment management approach is delivering outperformance across a range of equity and fixed income strategies."

 

Notes

Local currency AuM includes US$6.3 billion of AuM managed in overlay/liquidity strategies (31 March 2023: US$6.3 billion).

For the translation of US dollar-denominated balance sheet items, the GBP:USD exchange rate was 1.2714 at 30 June 2023 (30 June 2022: 1.2145; 31 December 2022: 1.2029). For the translation of US dollar management fees, the average GBP:USD exchange rate for the financial year was 1.2079 (FY2021/22: 1.3289).

Ashmore will announce its results in respect of the year ending 30 June 2023 on 6 September 2023.

 

For further information please contact:

Ashmore Group plcPaul MeasdayInvestor Relations +44 (0)20 3077 6278

FTI ConsultingNeil Doyle +44 (0)7771 978 220Kit Dunford +44 (0)7717 417 038

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFVRDIIVLIV
Date   Source Headline
5th Oct 20226:03 pmRNSHolding(s) in Company
23rd Sep 20224:56 pmRNSDirector/PDMR Shareholding
15th Sep 202210:36 amRNSDirector/PDMR Shareholding
14th Sep 20226:00 pmRNSHolding(s) in Company
9th Sep 20225:19 pmRNSNotice of AGM
2nd Sep 20227:00 amRNSFinal Results
22nd Jul 202211:33 amRNSDirectorate Change
14th Jul 20227:00 amRNSTrading Statement
25th Apr 20227:00 amRNSHolding(s) in Company
14th Apr 20227:00 amRNSTrading Statement
1st Apr 20223:02 pmRNSDirector/PDMR Shareholding
21st Mar 20224:30 pmRNSDirectorate Change
17th Mar 202211:35 amRNSDirector/PDMR Shareholding
17th Jan 20227:00 amRNSTrading Statement
13th Dec 202111:34 amRNSDirector/PDMR Shareholding
15th Oct 20213:42 pmRNSResult of AGM
14th Oct 20217:00 amRNSTrading Statement
23rd Sep 202112:27 pmRNSDirector/PDMR Shareholding
23rd Sep 202112:24 pmRNSDirector/PDMR Shareholding
17th Sep 20219:52 amRNSDirector/PDMR Shareholding
17th Sep 20219:48 amRNSDirector/PDMR Shareholding
10th Sep 20214:00 pmRNSNotice of AGM
3rd Sep 20217:00 amRNSFinal Results
14th Jul 20217:00 amRNSTrading Statement
30th Apr 20212:51 pmRNSDirector/PDMR Shareholding
23rd Apr 20213:12 pmRNSDirectorate Change
16th Apr 20217:00 amRNSTrading Statement
13th Apr 20213:45 pmRNSAGM voting result update statement
6th Apr 20212:54 pmRNSDirector/PDMR Shareholding
6th Apr 20212:37 pmRNSDirector/PDMR Shareholding
18th Mar 20216:02 pmRNSDirector/PDMR Shareholding
16th Feb 20214:35 pmRNSHolding(s) in Company
16th Feb 20214:29 pmRNSDirector/PDMR Shareholding
10th Feb 20217:00 amRNSHalf-year Report
15th Jan 20217:00 amRNSTrading Statement
11th Dec 20205:40 pmRNSDirector/PDMR Shareholding
11th Dec 20205:37 pmRNSDirector/PDMR Shareholding
19th Oct 20206:20 pmRNSHolding(s) in Company
19th Oct 20205:47 pmRNSDirector/PDMR Shareholding
16th Oct 20204:14 pmRNSResult of AGM
14th Oct 20207:00 amRNSTrading Statement
7th Oct 20209:42 amRNSHolding(s) in Company
25th Sep 20202:20 pmRNSAGM arrangements
22nd Sep 20206:04 pmRNSDirector/PDMR Shareholding
22nd Sep 20206:03 pmRNSDirector/PDMR Shareholding
22nd Sep 20208:26 amRNSDirector/PDMR Shareholding
16th Sep 20204:09 pmRNS2020 Annual Financial Report and Notice of AGM
11th Sep 20207:00 amRNSFinal Results
14th Jul 20207:00 amRNSTrading Statement
23rd Jun 20205:40 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.